Advances in Bacterial Methionine Aminopeptidase Inhibition

Travis R Helgren, Phumvadee Wangtrakuldee, Bart L Staker

  • 1Northern Illinois University, Department of Chemistry and Biochemistry, DeKalb, IL 60115 USA. thagen@niu.edu.

Insights

Methionine aminopeptidases (MetAPs) are essential bacterial enzymes and potential drug targets. Structural analysis reveals differences between bacterial and human MetAPs, guiding the development of selective antibacterial agents.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Medicinal Chemistry

Background:

  • Methionine aminopeptidases (MetAPs) are essential metalloenzymes in bacteria, crucial for protein synthesis.
  • MetAP activity is vital for bacterial survival, identifying them as promising antibacterial drug targets.
  • Human MetAPs share structural similarities, necessitating selective inhibition strategies.

Purpose of the Study:

  • To review crystallographic data of bacterial MetAPs.
  • To compare bacterial and human MetAP structures for selectivity insights.
  • To analyze the chemical diversity of bacterial MetAP inhibitors.

Main Methods:

  • Crystallographic data analysis of bacterial MetAPs.
  • Comparative structural analysis between bacterial and human MetAPs.
  • Review of chemical inhibitors targeting bacterial MetAPs.

Main Results:

  • Over 65 bacterial MetAP crystal structures are available in the PDB.
  • Structural differences between bacterial and human MetAPs identified.
  • Diverse chemical scaffolds inhibit bacterial MetAP enzymes.

Conclusions:

  • Bacterial MetAPs represent a viable target for novel antibacterial drug development.
  • Structural comparisons facilitate the design of selective inhibitors.
  • Understanding inhibitor chemical space aids in developing effective antibacterial agents.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
54
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
83
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
41
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
113
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.6K